Induction of differential apoptotic pathways in multiple myeloma cells by class selective histone deacetylase inhibitors

Những quyển sách tương tự

• Histone deacetylase 3 (HDAC3) as a novel therapeutic target in multiple myeloma
  Bằng: Minami, Jiro, et al.
  Được phát hành: (2013)
• New Insights into the Treatment of Multiple Myeloma with Histone Deacetylase Inhibitors
  Bằng: Cea, Michele, et al.
  Được phát hành: (2013)
• Rational combination treatment with histone deacetylase inhibitors and immunomodulatory drugs in multiple myeloma
  Bằng: Hideshima, T, et al.
  Được phát hành: (2015)
• Immunomodulatory effects of lenalidomide and pomalidomide on interaction of tumor and bone marrow accessory cells in multiple myeloma
  Bằng: Görgün, Güllü, et al.
  Được phát hành: (2010)
• Histone deacetylase (HDAC) inhibitor ACY241 enhances anti-tumor activities of antigen-specific central memory cytotoxic T lymphocytes against multiple myeloma and solid tumors
  Bằng: Bae, Jooeun, et al.
  Được phát hành: (2018)